JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged)
WKN A2PR30 | ISIN LU2053353665 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU0208607159 | Pictet - Biotech - P dy USD | +73,51 % | +22,44 % | 3,16 |
|
| 2 | LU0320646986 | Pictet - Biotech - P dy GBP | +71,52 % | +22,51 % | 3,07 |
|
| 3 | LU0108459552 | Candriam Equities L Biotechnology, C - Distribution | +62,40 % | +21,63 % | 2,77 |
|
| 4 | IE00B3VXGD32 | Polar Capital Funds plc - Biotechnology Fund Class R EUR Distribution Shares | +62,46 % | +24,39 % | 2,46 |
|
| 5 | IE00BF23BV98 | Polar Capital Funds plc - Biotechnology Fund Class S USD Distribution Shares | +63,41 % | +25,15 % | 2,42 |
|
| 13 | LU2053353749 | JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged) | +40,89 % | +20,35 % | 1,89 |
|
| 14 | LU2053353665 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | +40,09 % | +20,35 % | 1,85 |
|
| 15 | DE000A2DU172 | Allianz Biotechnologie - P - EUR | +37,17 % | +20,64 % | 1,68 |
|
| 16 | DE000A2AMPU5 | Allianz Biotechnologie - R - EUR | +37,01 % | +20,64 % | 1,67 |
|
| 17 | DE0008481862 | Allianz Biotechnologie - A - EUR | +35,82 % | +20,64 % | 1,61 |
|